D7H-11182-08719
2 vaccinations
1 coded response
13 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 021 / MA
- Registered
- 2021-05-31
- Relationship
- Self
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-28
Dose 1 — Pfizer-BioNTech
-
2021-05-31
Registered in v-safe
- 2021-06-01
- 2021-06-02
- 2021-06-04
- 2021-06-11
- 2021-06-18
-
2021-06-20
Dose 2 — Pfizer-BioNTech
- 2021-06-25
- 2021-06-27
- 2021-07-04
- 2021-07-13
- 2021-07-18
- 2021-07-25
- 2021-08-03
-
2021-09-24
Survey response — 3 months, dose 2MedDRA: Dyspnoea — Feeling: Fair · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Shortness of breathMedDRA releases: 2024-11 · check-in free text available
-
2021-09-24
Report sent to call center — 3 months, dose 2Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2021-09-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-28 | Pfizer-BioNTech | |
| 2 | 2021-06-20 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 9 — 3 months, dose 2
Symptoms: Shortness of breath
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Dyspnoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release